Translational implications of the β-cell epigenome in diabetes mellitus

Translational Research

Volumn 165, Issue 1, 2015, Pages 91-101

  Johnson, Justin S ^a   Evans Molina, Carmella ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; E1A ASSOCIATED P300 PROTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; INSULIN; UNTRANSLATED RNA;

CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CPG ISLAND; DIABETES MELLITUS; DNA CONFORMATION; DNA METHYLATION; DNA SEQUENCE; DNA TRANSCRIPTION; ENDOPLASMIC RETICULUM STRESS; EPIGENETIC REPRESSION; EPIGENETICS; ESSENTIAL GENE; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; HETEROCHROMATIN; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRENATAL GROWTH; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PROTEIN PROCESSING; TRANSLATIONAL RESEARCH;

ANIMALS; DIABETES MELLITUS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; INSULIN-SECRETING CELLS; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84919841620     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.03.002     Document Type: Review

References (134)

1. L. Guariguata, D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J.E. Shaw Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas Diabetes Res Clin Pract 103 2014 137 149
2. P. Cammidge Heredity as a factor in the aetiology of diabetes mellitus Lancet 223 1934 393 395
3. A.G. Steinberg, and R.M. Wilder A study of the genetics of diabetes mellitus Am J Hum Genet 4 1952 113 135
4. F.S. Collins, and V.A. McKusick Implications of the Human Genome Project for medical science JAMA 285 2001 540 544
5. K. Almind, A. Doria, and C.R. Kahn Putting the genes for type II diabetes on the map Nat Med 7 2001 277 279
6. R. Bergholdt, C. Brorsson, and A. Palleja Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression Diabetes 61 2012 954 962
7. C. Polychronakos, and Q. Li Understanding type 1 diabetes through genetics: advances and prospects Nat Rev Genet 12 2011 781 792
8. B.E. Bernstein, A. Meissner, and E.S. Lander The mammalian epigenome Cell 128 2007 669 681
9. A.P. Wolffe, and M.A. Matzke Epigenetics: regulation through repression Science 286 1999 481 486
10. A. Bird Perceptions of epigenetics Nature 447 2007 396 398
11. H.A. Jamniczky, J.C. Boughner, and C. Rolian Rediscovering Waddington in the post-genomic age: operationalising Waddington's epigenetics reveals new ways to investigate the generation and modulation of phenotypic variation Bioessays 32 2010 553 558
12. J.M. Perkel Visiting "noncodarnia" Biotechniques 54 2013 3 4
13. V. Nesca, C. Guay, and C. Jacovetti Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes Diabetologia 56 2013 2203 2212
14. R.W. Carthew, and E.J. Sontheimer Origins and mechanisms of miRNAs and siRNAs Cell 136 2009 642 655
15. D.N. Cooper, and M. Krawczak Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes Hum Genet 83 1989 181 188
16. K.D. Robertson, and P.A. Jones DNA methylation: past, present and future directions Carcinogenesis 21 2000 461 467
17. J. Sandoval, H. Heyn, and S. Moran Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome Epigenetics 6 2011 692 702
18. M.J. Ziller, F. Muller, and J. Liao Genomic distribution and inter-sample variation of non-CpG methylation across human cell types PLoS Genet 7 2011 e1002389
19. A.K. Maunakea, R.P. Nagarajan, and M. Bilenky Conserved role of intragenic DNA methylation in regulating alternative promoters Nature 466 2010 253 257
20. J.M. Cramer, J.N. Scarsdale, N.M. Walavalkar, W.A. Buchwald, G.D. Ginder, and D.C. Williams Jr. Probing the dynamic distribution of bound states for methyl-cytosine binding domains on DNA J Biol Chem 289 2013 1294 1302
21. E.R. Gilbert, and D. Liu Epigenetics: the missing link to understanding beta-cell dysfunction in the pathogenesis of type 2 diabetes Epigenetics 7 2012 841 852
22. E.U. Selker, M. Freitag, and G.O. Kothe Induction and maintenance of nonsymmetrical DNA methylation in Neurospora Proc Natl Acad Sci U S A 99 2002 16485 16490
23. T.A. Volpe, C. Kidner, I.M. Hall, G. Teng, S.I. Grewal, and R.A. Martienssen Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi Science 297 2002 1833 1837
24. Y. Zhang, and D. Reinberg Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails Gene Dev 15 2001 2343 2360
25. S. Eden, T. Hashimshony, I. Keshet, H. Cedar, and A.W. Thorne DNA methylation models histone acetylation Nature 394 1998 842
26. D.A. Babu, T.G. Deering, and R.G. Mirmira A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis Mol Genet Metab 92 2007 43 55
27. F. Fuks, P.J. Hurd, D. Wolf, X. Nan, A.P. Bird, and T. Kouzarides The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation J Biol Chem 278 2003 4035 4040
28. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
29. I. Akerman, J. van Arensbergen, and J. Ferrer Removing the brakes on cell identity Dev Cell 20 2011 411 412
30. J. van Arensbergen, J. Garcia-Hurtado, and I. Moran Derepression of polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program Genome Res 20 2010 722 732
31. S. Dhawan, S. Georgia, S.I. Tschen, G. Fan, and A. Bhushan Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx Dev Cell 20 2011 419 429
32. J.H. Park, D.A. Stoffers, R.D. Nicholls, and R.A. Simmons Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1 J Clin Invest 118 2008 2316 2324
33. A. Kuroda, T.A. Rauch, and I. Todorov Insulin gene expression is regulated by DNA methylation PLoS One 4 2009 e6953
34. E.M. Akirav, J. Lebastchi, and E.M. Galvan Detection of β cell death in diabetes using differentially methylated circulating DNA Proc Natl Acad Sci U S A 108 2011 19018 19023
35. M.M. Fisher, C.N. Perez Chumbiauca, K.J. Mather, R.G. Mirmira, and S.A. Tersey Detection of islet beta-cell death in vivo by multiplex PCR analysis of differentially methylated DNA Endocrinology 154 2013 3476 3481
36. I.K. Temple, R.J. Gardner, D.J. Mackay, J.C. Barber, D.O. Robinson, and J.P. Shield Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes Diabetes 49 2000 1359 1366
37. L.E. Docherty, R.L. Poole, C.J. Mattocks, A. Lehmann, I.K. Temple, and D.J. Mackay Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes Diabetologia 53 2010 2347 2351
38. C. Diatloff-Zito, A. Nicole, and G. Marcelin Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical region J Med Genet 44 2007 31 37
39. D.J. Mackay, J.L. Callaway, and S.M. Marks Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 Nat Genet 40 2008 949 951
40. X. Du, H. Ounissi-Benkalha, M.K. Loder, G.A. Rutter, and C. Polychronakos Overexpression of ZAC impairs glucose-stimulated insulin translation and secretion in clonal pancreatic beta-cells Diabetes Metab Res Rev 28 2012 645 653
41. D. Meyre, N. Bouatia-Naji, and A. Tounian Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes Nat Genet 37 2005 863 867
42. M.M. Sale, B.I. Freedman, and C.D. Langefeld A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q Diabetes 53 2004 830 837
43. M. Volkmar, S. Dedeurwaerder, and D.A. Cunha DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients EMBO J 31 2012 1405 1426
44. G.C. Weir, D.R. Laybutt, H. Kaneto, S. Bonner-Weir, and A. Sharma Beta-cell adaptation and decompensation during the progression of diabetes Diabetes 50 2001 S154 S159
45. M. Imamura, and S. Maeda Genetics of type 2 diabetes: the GWAS era and future perspectives [review] Endocrine J 58 2011 723 739
46. B.F. Voight, L.J. Scott, and V. Steinthorsdottir Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis Nat Genet 42 2010 579 589
47. F.Y. Wei, K. Nagashima, and T. Ohshima CDK5-dependent regulation of glucose-stimulated insulin secretion Nat Med 11 2005 1104 1108
48. J.F. Habener, and D.A. Stoffers A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus Proc Assoc Am Phys 110 1998 12 21
49. M. Ubeda, J.M. Rukstalis, and J.F. Habener Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity J Biol Chem 281 2006 28858 28864
50. T. Kono, G. Ahn, and D.R. Moss PPAR-gamma activation restores pancreatic islet SERCA2 levels and prevents beta-cell dysfunction under conditions of hyperglycemic and cytokine stress Mol Endocrinol 26 2012 257 271
51. C. Talchai, S. Xuan, V. Lin Hua, L. Sussel, and D. Accili Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure Cell 150 2012 1223 1234
52. T. Brun, I. Franklin, and L. St-Onge The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets J Cell Biol 167 2004 1123 1135
53. T. Brun, D.L. Duhamel, K.H. Hu He, C.B. Wollheim, and B.R. Gauthier The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells Oncogene 26 2007 4261 4271
54. S.B. Smith, H. Watada, D.W. Scheel, C. Mrejen, and M.S. German Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter J Biol Chem 275 2000 36910 36919
55. N. Plengvidhya, S. Kooptiwut, and N. Songtawee PAX4 mutations in Thais with maturity onset diabetes of the young J Clin Endocrinol Metab 92 2007 2821 2826
56. Y. Shimajiri, T. Sanke, and H. Furuta A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese Diabetes 50 2001 2864 2869
57. A. Kanatsuka, Y. Tokuyama, O. Nozaki, K. Matsui, and T. Egashira Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4 Metabolism 51 2002 1161 1165
58. P. Holm, B. Rydlander, H. Luthman, and I. Kockum Interaction and association analysis of a type 1 diabetes susceptibility locus on chromosome 5q11-q13 and the 7q32 chromosomal region in Scandinavian families Diabetes 53 2004 1584 1591
59. L. Bouwens, and I. Rooman Regulation of pancreatic beta-cell mass Physiol Rev 85 2005 1255 1270
60. K. Al-Hasani, A. Pfeifer, and M. Courtney Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes Dev Cell 26 2013 86 100
61. P. Collombat, X. Xu, and P. Ravassard The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells Cell 138 2009 449 462
62. T.A. Dayeh, A.H. Olsson, P. Volkov, P. Almgren, T. Ronn, and C. Ling Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets Diabetologia 56 2013 1036 1046
63. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
64. B. Ahren, and O. Schmitz GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes Hormone Metab Res 36 2004 867 876
65. Y. Li, T. Hansotia, B. Yusta, F. Ris, P.A. Halban, and D.J. Drucker Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis J Biol Chem 278 2003 471 478
66. E. Hall, T. Dayeh, C.L. Kirkpatrick, C.B. Wollheim, M. Dekker Nitert, and C. Ling DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets BMC Med Genet 14 2013 76
67. F. Guenard, Y. Deshaies, K. Cianflone, J.G. Kral, P. Marceau, and M.C. Vohl Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery Proc Natl Acad Sci U S A 110 2013 11439 11444
68. M.E. Patti Reducing maternal weight improves offspring metabolism and alters (or modulates) methylation Proc Natl Acad Sci U S A 110 2013 12859 12860
69. D.T. Johnson, R.A. Harris, P.V. Blair, and R.S. Balaban Functional consequences of mitochondrial proteome heterogeneity Am J Physiol Cell Physiol 292 2007 C698 C707
70. D.T. Johnson, R.A. Harris, and S. French Tissue heterogeneity of the mammalian mitochondrial proteome Am J Physiol Cell Physiol 292 2007 C689 C697
71. Y. Wang, W. Fischle, W. Cheung, S. Jacobs, S. Khorasanizadeh, and C.D. Allis Beyond the double helix: writing and reading the histone code Novartis Found Symp 259 2004 3 17 discussion 17-21, 163-9
72. K. Ahmad, and S. Henikoff The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly Mol Cell 9 2002 1191 1200
73. P.S. Kayne, U.J. Kim, M. Han, J.R. Mullen, F. Yoshizaki, and M. Grunstein Extremely conserved histone H4 N terminus is dispensable for growth but essential for repressing the silent mating loci in yeast Cell 55 1988 27 39
74. B.M. Turner Cellular memory and the histone code Cell 111 2002 285 291
75. E.J. Richards, and S.C. Elgin Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects Cell 108 2002 489 500
76. S.K. Chakrabarti, J. Frances, S. Ziesmnn, J.C. Garmey, and R.G. Mirmira Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic B cells J Biol Chem 278 2003 23617 23623
77. K. Struhl Histone acetylation and transcriptional regulatory mechanisms Genes Dev 12 1998 599 606
78. M. Lundh, D.P. Christensen, and D.N. Rasmussen Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines Diabetologia 53 2010 2569 2578
79. D.P. Christensen, M. Dahllof, and M. Lundh Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus Mol Med 17 2011 378 390
80. M. Braunstein, A.B. Rose, S.G. Holmes, C.D. Allis, and J.R. Broach Transcriptional silencing in yeast is associated with reduced nucleosome acetylation Genes Dev 7 1993 592 604
81. B.M. Turner Histone acetylation and an epigenetic code Bioessays 22 2000 836 845
82. Q. Ren, and M.A. Gorovsky The nonessential H2A N-terminal tail can function as an essential charge patch on the H2A.Z variant N-terminal tail Mol Cell Biol 23 2003 2778 2789
83. F. Winston, and C.D. Allis The bromodomain: a chromatin-targeting module? Nat Struct Biol 6 1999 601 604
84. A.H. Hassan, P. Prochasson, and K.E. Neely Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes Cell 111 2002 369 379
85. E.L. Greer, and Y. Shi Histone methylation: a dynamic mark in health, disease and inheritance Nat Rev Genet 13 2012 343 357
86. K. Noma, C.D. Allis, and S.I. Grewal Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries Science 293 2001 1150 1155
87. Y. Shi, F. Lan, and C. Matson Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
88. R.J. Klose, E.M. Kallin, and Y. Zhang JmjC-domain-containing proteins and histone demethylation Nat Rev Genet 7 2006 715 727
89. F. Forneris, C. Binda, A. Dall'Aglio, M.W. Fraaije, E. Battaglioli, and A. Mattevi A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1 J Biol Chem 281 2006 35289 35295
90. K. Robzyk, J. Recht, and M.A. Osley Rad6-dependent ubiquitination of histone H2B in yeast Science 287 2000 501 504
91. Z.W. Sun, and C.D. Allis Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast Nature 418 2002 104 108
92. S. Rea, F. Eisenhaber, and D. O'Carroll Regulation of chromatin structure by site-specific histone H3 methyltransferases Nature 406 2000 593 599
93. P. Collombat, J. Hecksher-Sørensen, and J. Krull Embryonic endocrine pancreas and mature β cells acquire α and PP cell phenotypes upon Arx misexpression J Clin Invest 117 2007 961 970
94. C. Haumaitre, O. Lenoir, and R. Scharfmann Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors Mol Cell Biol 28 2008 6373 6383
95. O. Lenoir, K. Flosseau, and F.X. Ma Specific control of pancreatic endocrine beta- and delta-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9 Diabetes 60 2011 2861 2871
96. S.K. Chakrabarti, J.C. James, and R.G. Mirmira Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1: importance of chromatin structure in directing promoter binding J Biol Chem 277 2002 13286 13293
97. V. Mutskov, and G. Felsenfeld The human insulin gene is part of a large open chromatin domain specific for human islets Proc Natl Acad Sci U S A 106 2009 17419 17424
98. M.L. Stitzel, P. Sethupathy, and D.S. Pearson Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci Cell Metab 12 2010 443 455
99. R. Bhandare, J. Schug, and J. Le Lay Genome-wide analysis of histone modifications in human pancreatic islets Genome Res 20 2010 428 433
100. S. Malmgren, P. Spegel, and A.P. Danielsson Coordinate changes in histone modifications, mRNA levels, and metabolite profiles in clonal INS-1 832/13 beta-cells accompany functional adaptations to lipotoxicity J Biol Chem 288 2013 11973 11987
101. J. Zhou, and W.J. Chng Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer Mitochondrion 13 2013 163 169
102. H. Cha-Molstad, G. Saxena, J. Chen, and A. Shalev Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells J Biol Chem 284 2009 16898 16905
103. N. Poungvarin, J.K. Lee, and V.K. Yechoor Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity Diabetologia 55 2012 1783 1796
104. S.J. Burke, B.L. Updegraff, and R.M. Bellich Regulation of iNOS gene transcription by IL-1beta and IFN-gamma requires a coactivator exchange mechanism Mol Endocrinol 27 2013 1724 1742
105. A.L. Mosley, and S. Ozcan Glucose regulates insulin gene transcription by hyperacetylation of histone h4 J Biol Chem 278 2003 19660 19666
106. H.W. Wang, M.B. Breslin, and M.S. Lan Pdx-1 modulates histone H4 acetylation and insulin gene expression in terminally differentiated alpha-TC-1 cells Pancreas 34 2007 248 253
107. S.S. Andrali, M.L. Sampley, N.L. Vanderford, and S. Ozcan Glucose regulation of insulin gene expression in pancreatic beta-cells Biochem J 415 2008 1 10
108. A.L. Mosley, and S. Ozcan The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases HDAC-1 and HDAC-2 on low levels of glucose J Biol Chem 279 2004 54241 54247
109. T.G. Deering, T. Ogihara, A.P. Trace, B. Maier, and R.G. Mirmira Methyltransferase SET7/9 maintains transcription and euchromatin structure at islet-enriched genes Diabetes 58 2009 185 193
110. C. Evans-Molina, R.D. Robbins, and T. Kono Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure Mol Cell Biol 29 2009 2053 2067
111. H. Chen, X. Gu, and Y. Liu PDGF signalling control subjects age-dependent proliferation in pancreatic beta-cells Nature 478 2011 349 355
112. H. Chen, X. Gu, and I.H. Su Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus Gene Dev 23 2009 975 985
113. J.X. Zhou, S. Dhawan, and H. Fu Combined modulation of polycomb and trithorax genes rejuvenates beta cell replication J Clin Invest 123 2013 4849 4858
114. R.A. Simmons, L.J. Templeton, and S.J. Gertz Intrauterine growth retardation leads to the development of type 2 diabetes in the rat Diabetes 50 2001 2279 2286
115. D.J. Barker, C.N. Hales, C.H. Fall, C. Osmond, K. Phipps, and P.M. Clark Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth Diabetologia 36 1993 62 67
116. D.A. Stoffers, B.M. Desai, D.D. DeLeon, and R.A. Simmons Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat Diabetes 52 2003 734 740
117. S.E. Pinney, L.J. Jaeckle Santos, Y. Han, D.A. Stoffers, and R.A. Simmons Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat Diabetologia 54 2011 2606 2614
118. R.F. Thompson, M.J. Fazzari, H. Niu, N. Barzilai, R.A. Simmons, and J.M. Greally Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats J Biol Chem 285 2010 15111 15118
119. S.F. Ng, R.C. Lin, D.R. Laybutt, R. Barres, J.A. Owens, and M.J. Morris Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring Nature 467 2010 963 966
120. K.A. Bode, K. Schroder, and D.A. Hume Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment Immunology 122 2007 596 606
121. M. Lundh, D.P. Christensen, and M. Damgaard Nielsen Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children Diabetologia 55 2012 2421 2431
122. D.P. Christensen, C. Gysemans, and M. Lundh Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection Proc Natl Acad Sci 111 2014 1055 1059
123. S.M. Cabrera, S.C. Colvin, S.A. Tersey, B. Maier, J.L. Nadler, and R.G. Mirmira Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes Clin Exp Immunol 172 2013 375 382
124. M.M. Mihaylova, D.S. Vasquez, and K. Ravnskjaer Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis Cell 145 2011 607 621
125. S. Kubicek, and T. Jenuwein A crack in histone lysine methylation Cell 119 2004 903 906
126. H.O. Buschiazzo, B. Mordujovich de, R.E. Hernandez, and R.R. Rodriguez Preventive action of tranylcypromine on alloxan diabetes in rats Diabetes 16 1967 810 812
127. P.I. Adnitt Hypoglycemic action of monoamineoxidase inhibitors (MAOI'S) Diabetes 17 1968 628 633
128. W.Z. Potter, D.S. Zaharko, and L.V. Beck Possible role of hydrazine group in hypoglycemia associated with the use of certain monoamine-oxidase inhibitors (MAOI's) Diabetes 18 1969 538 541
129. M. Cnop, N. Welsh, J.C. Jonas, A. Jorns, S. Lenzen, and D.L. Eizirik Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 2005 S97 107
130. F.K. Gorus, B. Keymeulen, P.A. Veld, and D.G. Pipeleers Predictors of progression to type 1 diabetes: preparing for immune interventions in the preclinical disease phase Exp Rev Clin Immunol 9 2013 1173 1183
131. M.I. Husseiny, A. Kuroda, A.N. Kaye, I. Nair, F. Kandeel, and K. Ferreri Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes PLoS One 7 2012 e47942
132. J. Lebastchi, S. Deng, and A.H. Lebastchi Immune therapy and beta-cell death in type 1 diabetes Diabetes 62 2013 1676 1680
133. H. Schwarzenbach, D.S. Hoon, and K. Pantel Cell-free nucleic acids as biomarkers in cancer patients Nat Rev Cancer 11 2011 426 437
134. D.W. Bianchi Circulating fetal DNA: its origin and diagnostic potential-a review Placenta 25 2004 S93 101